Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide.
- Loading stock data...

Average yearly return: +45%
Fair value: 265€

Based on dynamic business performance in the first six months of 2020 and on expectations that demand will remain high for the rest of the year, Stedim raised its growth and earnings forecast for fiscal 2020.
Strong buy | |
Buy | |
Wait | |
X | |
Sell | |
Strong sell |
If you found this site useful and want to help keep it alive,

to cover the costs and keep the site free of advertisements! Thank you for your support!